UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.036

Sortiert nach

Myeloid suppressor cell depletion augments antitumor activity in lung cancer

PloS one, 2012-07, Vol.7 (7), p.e40677-e40677

2012

Volltextzugriff (PDF)

Proteomic Analysis of Human Saliva From Lung Cancer Patients Using Two-Dimensional Difference Gel Electrophoresis and Mass Spectrometry

Molecular & cellular proteomics, 2012-02, Vol.11 (2), p.M111.012112-M111.012112, Article M111.012112

2012

Volltextzugriff (PDF)

Risk stratification of patients undergoing pulmonary metastasectomy for soft tissue and bone sarcomas

The Journal of thoracic and cardiovascular surgery, 2015, Vol.149 (1), p.85-92

2015

Volltextzugriff (PDF)

Neoadjuvant, perioperative, or adjuvant immunotherapy in resectable non–small cell lung cancer: How do I choose? Importance of immune biomarkers and molecular testing

The Journal of thoracic and cardiovascular surgery, 2024-04

Lee, Jay M.

2024

Volltextzugriff (PDF)

Development of transcriptomic biomarker signature in human saliva to detect lung cancer

Cellular and molecular life sciences : CMLS, 2012-10, Vol.69 (19), p.3341-3350

2012

Volltextzugriff (PDF)

Surgical Perspective on Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer

The Annals of thoracic surgery, 2022-10, Vol.114 (4), p.1505-1515

2022

Volltextzugriff (PDF)

Commentary: The search for a chemotherapy-free immunotherapy regimen in resectable non–small cell lung cancer: The unmet need

The Journal of thoracic and cardiovascular surgery, 2023-01, Vol.165 (1), p.335-336

Lee, Jay M.

2023

Volltextzugriff (PDF)

Classification of Non-Small Cell Lung Cancer’s Tumor Immune Micro-Environment and Strategies to Augment Its Response to Immune Checkpoint Blockade

Cancers, 2021-06, Vol.13 (12), p.2924

2021

Volltextzugriff (PDF)

Comparative Efficacy of Neoadjuvant Nivolumab Plus Chemotherapy versus Conventional Comparator Treatments in Resectable Non-Small-Cell Lung Cancer: A Systematic Literature Review and Network Meta-Analysis

Cancers, 2024-07, Vol.16 (13), p.2492

2024

Volltextzugriff (PDF)

IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer

Journal of experimental & clinical cancer research, 2013-11, Vol.32 (1), p.97-97, Article 97

2013

Volltextzugriff (PDF)

Arrhythmic Risk Profile and Outcomes of Patients Undergoing Cardiac Sympathetic Denervation for Recurrent Monomorphic Ventricular Tachycardia After Ablation

Journal of the American Heart Association, 2021-01, Vol.10 (2), p.e018371-e018371

2021

Volltextzugriff (PDF)

Snail Promotes CXCR2 Ligand–Dependent Tumor Progression in Non–Small Cell Lung Carcinoma

Clinical cancer research, 2009-11, Vol.15 (22), p.6820-6829

2009

Volltextzugriff (PDF)

Important Surgical and Clinical End Points in Neoadjuvant Immunotherapy Trials in Resectable NSCLC

JTO clinical and research reports, 2021-10, Vol.2 (10), p.100221-100221, Article 100221

2021

Volltextzugriff (PDF)

Primary salivary duct carcinoma of the lung, mucin-rich variant

Human pathology, 2016-01, Vol.47 (1), p.150-156

2016

Volltextzugriff (PDF)

Economic Burden of Recurrence Among Resected Medicare Patients With Early Stage NSCLC

JTO clinical and research reports, 2023-04, Vol.4 (4), p.100487-100487, Article 100487

2023

Volltextzugriff (PDF)

Pathophysiology and Management of Chest Wall Pain after Surgical and Non-Surgical Local Therapies for Lung Cancer

JTO clinical and research reports, 2024-07, Vol.5 (7), p.100690, Article 100690

2024

Volltextzugriff (PDF)

Immune Checkpoint Blockade Enhances Immune Activity of Therapeutic Lung Cancer Vaccine

Vaccines (Basel), 2020-11, Vol.8 (4), p.655

2020

Volltextzugriff (PDF)

Phase I Trial of Intratumoral Injection of CCL21 Gene-Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8 + T-cell Infiltration

Clinical cancer research, 2017-08, Vol.23 (16), p.4556-4568

2017

Volltextzugriff (PDF)

Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial

Nature medicine, 2022-10, Vol.28 (10), p.2155-2161

2022

Volltextzugriff (PDF)

Technical Feasibility and Safety of Repeated Computed Tomography–Guided Transthoracic Intratumoral Injection of Gene-Modified Cellular Immunotherapy in Metastatic NSCLC

JTO clinical and research reports, 2021-11, Vol.2 (11), p.100242-100242, Article 100242

2021

Volltextzugriff (PDF)

The Evolving Epidemiology and Management of Spontaneous Pneumothorax

JAMA : the journal of the American Medical Association, 2018-10, Vol.320 (14), p.1441

2018

Volltextzugriff (PDF)

Real-world adjuvant chemotherapy patterns and outcomes among elderly patients with resected early non-small-cell lung cancer in the USA

Future oncology (London, England), 2023-01, Vol.19 (1), p.37-47

2023

Volltextzugriff (PDF)

Surgical Management of Endobronchial Solitary Fibrous Tumors

The Annals of thoracic surgery, 2010-08, Vol.90 (2), p.659-661

2010

Volltextzugriff (PDF)

Safety of adjuvant atezolizumab after pneumonectomy/bilobectomy in stage II-IIIA non-small cell lung cancer in the randomized phase III IMpower010 trial

The Journal of thoracic and cardiovascular surgery, 2023-09, Vol.166 (3), p.655-666.e7

2023

Volltextzugriff (PDF)

Neoadjuvant Targeted Therapy in Resectable NSCLC: Current and Future Perspectives

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.1458-1477

2023

Volltextzugriff (PDF)

1 – 25 von 2.036

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.818)
Mit Volltextzugriff
(1.771)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Myeloid suppressor cell depletion augments antitumor activity in lung cancer

Proteomic Analysis of Human Saliva From Lung Cancer Patients Using Two-Dimensional Difference Gel Electrophoresis and Mass Spectrometry

Risk stratification of patients undergoing pulmonary metastasectomy for soft tissue and bone sarcomas

Neoadjuvant, perioperative, or adjuvant immunotherapy in resectable non–small cell lung cancer: How do I choose? Importance of immune biomarkers and molecular testing

Development of transcriptomic biomarker signature in human saliva to detect lung cancer

Surgical Perspective on Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer

Commentary: The search for a chemotherapy-free immunotherapy regimen in resectable non–small cell lung cancer: The unmet need

Classification of Non-Small Cell Lung Cancer’s Tumor Immune Micro-Environment and Strategies to Augment Its Response to Immune Checkpoint Blockade

Comparative Efficacy of Neoadjuvant Nivolumab Plus Chemotherapy versus Conventional Comparator Treatments in Resectable Non-Small-Cell Lung Cancer: A Systematic Literature Review and Network Meta-Analysis

IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer

Arrhythmic Risk Profile and Outcomes of Patients Undergoing Cardiac Sympathetic Denervation for Recurrent Monomorphic Ventricular Tachycardia After Ablation

Snail Promotes CXCR2 Ligand–Dependent Tumor Progression in Non–Small Cell Lung Carcinoma

Important Surgical and Clinical End Points in Neoadjuvant Immunotherapy Trials in Resectable NSCLC

Primary salivary duct carcinoma of the lung, mucin-rich variant

Economic Burden of Recurrence Among Resected Medicare Patients With Early Stage NSCLC

Pathophysiology and Management of Chest Wall Pain after Surgical and Non-Surgical Local Therapies for Lung Cancer

Immune Checkpoint Blockade Enhances Immune Activity of Therapeutic Lung Cancer Vaccine

Phase I Trial of Intratumoral Injection of CCL21 Gene-Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8 + T-cell Infiltration

Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial

Technical Feasibility and Safety of Repeated Computed Tomography–Guided Transthoracic Intratumoral Injection of Gene-Modified Cellular Immunotherapy in Metastatic NSCLC

The Evolving Epidemiology and Management of Spontaneous Pneumothorax

Real-world adjuvant chemotherapy patterns and outcomes among elderly patients with resected early non-small-cell lung cancer in the USA

Surgical Management of Endobronchial Solitary Fibrous Tumors

Safety of adjuvant atezolizumab after pneumonectomy/bilobectomy in stage II-IIIA non-small cell lung cancer in the randomized phase III IMpower010 trial

Neoadjuvant Targeted Therapy in Resectable NSCLC: Current and Future Perspectives

Suchergebnisse filtern